肿瘤药学
腫瘤藥學
종류약학
ANTI-TUMOR PHARMACY
2013年
3期
204-207,212
,共5页
刘桂超%胡学锋%黄国森%吕志倩%苏建淳%闵燕飞
劉桂超%鬍學鋒%黃國森%呂誌倩%囌建淳%閔燕飛
류계초%호학봉%황국삼%려지천%소건순%민연비
局部晚期鼻咽癌%诱导化疗%放射疗法%多西紫杉醇%顺铂%氟尿嘧啶
跼部晚期鼻嚥癌%誘導化療%放射療法%多西紫杉醇%順鉑%氟尿嘧啶
국부만기비인암%유도화료%방사요법%다서자삼순%순박%불뇨밀정
Locally advanced nasopharyngeal carcinoma%Neoadjuvant chemotherapy%Radiotherapy%Docetaxel%Cisplatin%5-FU
目的观察TPF方案与PF方案诱导化疗联合同期放化疗治疗局部晚期鼻咽癌的近期疗效及毒副反应。方法选取63例初诊的局部晚期鼻咽癌患者,随机分为试验组(TPF方案诱导化疗,31例)和对照组(PF方案诱导化疗,32例),诱导化疗2周期后均行同期放化疗,疗程结束后评价两组患者的近期疗效及毒副反应。结果两组的近期疗效比较差异无统计学意义(P=0.519),而试验组粒细胞减少的发生率显著高于对照组(P=0.020)。结论TPF方案与PF方案诱导化疗联合同期放化疗治疗局部晚期鼻咽癌的近期疗效相当,其远期疗效有待于进一步研究。
目的觀察TPF方案與PF方案誘導化療聯閤同期放化療治療跼部晚期鼻嚥癌的近期療效及毒副反應。方法選取63例初診的跼部晚期鼻嚥癌患者,隨機分為試驗組(TPF方案誘導化療,31例)和對照組(PF方案誘導化療,32例),誘導化療2週期後均行同期放化療,療程結束後評價兩組患者的近期療效及毒副反應。結果兩組的近期療效比較差異無統計學意義(P=0.519),而試驗組粒細胞減少的髮生率顯著高于對照組(P=0.020)。結論TPF方案與PF方案誘導化療聯閤同期放化療治療跼部晚期鼻嚥癌的近期療效相噹,其遠期療效有待于進一步研究。
목적관찰TPF방안여PF방안유도화료연합동기방화료치료국부만기비인암적근기료효급독부반응。방법선취63례초진적국부만기비인암환자,수궤분위시험조(TPF방안유도화료,31례)화대조조(PF방안유도화료,32례),유도화료2주기후균행동기방화료,료정결속후평개량조환자적근기료효급독부반응。결과량조적근기료효비교차이무통계학의의(P=0.519),이시험조립세포감소적발생솔현저고우대조조(P=0.020)。결론TPF방안여PF방안유도화료연합동기방화료치료국부만기비인암적근기료효상당,기원기료효유대우진일보연구。
Objective To compare the short-term efficacy and adverse reactions of TPF or PF neo-adjuvant chemotherapy com-bined with chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma. Methods Sixty three newly diagnosed locally advanced NPC patients were randomly divided into experimental group (TPF 31 case) and control group (PF 32 case). After two cycles of neo-adjuvant chemotherapy, all the patients underwent concurrent chemoradiotherapy. The short-term efficacy and adverse reaction of both groups were evaluated at the end of treatment. Results There were no significant differences in the short-term efficacy between the two groups (P=0.519). The incidence of neutropenia significantly increased in experimental group, as compared with control group (P=0.020). Conclusion TPF and PF neo-adjuvant chemotherapy combined with chemoradiotherapy had equal short-term clinical efficacy in the treatment of locally advanced nasopharyngeal carcinoma, while the long-term efficacies were still needed to be further researched.